Research Article
CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy
Table 2
Overall survival-3 years. This table shows an increase in overall survival after 3 years with tumors positive for CDK9 as compared to those negative for CDK9.
| ||||||||||||||||||||||||||||||||||||||||||||||||
Number of observations in the original data set = 84. Number of observations used = 67. |